Encision Reports Q2 Fiscal 2026 Results, Net Revenue Declines

Encision Inc., a medical device company known for its patented Active Electrode Monitoring (AEM®) technology, has released its financial results for the second quarter of fiscal year 2026, which ended on September 30, 2025. The company reported a total net revenue of $1.52 million, down from $1.76 million in the same period the previous year. This decline in revenue reflects a decrease in both product and service income.

In detail, Encision realized product net revenue of $1.48 million and service net revenue of $46 thousand for the quarter. Comparatively, the previous year’s results included product net revenue of $1.65 million and service net revenue of $102 thousand. The company posted a net loss of $268 thousand for the quarter, translating to $(0.02) per diluted share, compared to a net loss of $170 thousand or $(0.01) per diluted share in the same quarter of fiscal 2025.

Gross margin on product net revenue decreased slightly to 46% in the second quarter of fiscal 2026 from 47% in the prior year. This change indicates a modest shift in profitability linked to product sales.

Analysis of Financial Trends

The results highlight ongoing challenges for Encision as the company navigates a competitive medical device market. Despite the advanced AEM® technology designed to mitigate risks associated with radiant energy burns in minimally invasive surgeries, the financial performance indicates a need for strategic adjustments.

The decline in service revenue may reflect broader industry trends or shifts in demand for specific medical services. Encision’s management will likely need to evaluate their market strategies and operational efficiencies to address these challenges moving forward.

While the company is experiencing short-term setbacks, the long-term potential of AEM® technology remains significant within the surgical community. Encision’s commitment to innovation and patient safety positions it well for future growth.

In summary, Encision Inc.’s second quarter fiscal results reveal a decrease in revenue and an increase in net loss compared to the previous year. Leadership may need to implement strategic changes to foster future growth and capitalize on the potential of its patented technologies.